Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1972 1
1977 1
1981 1
1985 1
1987 2
1989 2
1990 1
1992 2
1993 3
1996 1
1997 3
1998 4
1999 2
2000 2
2001 1
2002 2
2003 1
2004 2
2005 1
2006 1
2009 2
2012 2
2013 3
2014 1
2015 4
2016 1
2017 4
2018 4
2019 3
2021 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Obesity and diabetes: the final frontier.
Rendell MS. Rendell MS. Expert Rev Endocrinol Metab. 2023 Jan;18(1):81-94. doi: 10.1080/17446651.2023.2168643. Epub 2023 Jan 29. Expert Rev Endocrinol Metab. 2023. PMID: 36710450 Review.
Albiglutide: a unique GLP-1 receptor agonist.
Rendell MS. Rendell MS. Expert Opin Biol Ther. 2016 Dec;16(12):1557-1569. doi: 10.1080/14712598.2016.1240780. Epub 2016 Oct 3. Expert Opin Biol Ther. 2016. PMID: 27677385 Review.
Aldose reductase inhibitors.
Kirchain WR, Rendell MS. Kirchain WR, et al. Among authors: rendell ms. Pharmacotherapy. 1990;10(5):326-36. Pharmacotherapy. 1990. PMID: 2122421 Review.
DPP-4 inhibitors: focus on safety.
Tella SH, Rendell MS. Tella SH, et al. Among authors: rendell ms. Expert Opin Drug Saf. 2015 Jan;14(1):127-40. doi: 10.1517/14740338.2015.977863. Epub 2014 Dec 9. Expert Opin Drug Saf. 2015. PMID: 25488788 Review.
Targeting postprandial hyperglycemia.
Rendell MS, Jovanovic L. Rendell MS, et al. Metabolism. 2006 Sep;55(9):1263-81. doi: 10.1016/j.metabol.2006.05.012. Metabolism. 2006. PMID: 16919548 Review.
Albiglutide for the management of type 2 diabetes.
Rendell MS. Rendell MS. Expert Rev Endocrinol Metab. 2018 Jan;13(1):1-8. doi: 10.1080/17446651.2018.1419061. Epub 2017 Dec 20. Expert Rev Endocrinol Metab. 2018. PMID: 30063441 Review.
Manifestations of cutaneous diabetic microangiopathy.
Ngo BT, Hayes KD, DiMiao DJ, Srinivasan SK, Huerter CJ, Rendell MS. Ngo BT, et al. Among authors: rendell ms. Am J Clin Dermatol. 2005;6(4):225-37. doi: 10.2165/00128071-200506040-00003. Am J Clin Dermatol. 2005. PMID: 16060710 Review.
Pharmacotherapy of type 2 diabetes mellitus.
Rendell MS, Kirchain WR. Rendell MS, et al. Ann Pharmacother. 2000 Jul-Aug;34(7-8):878-95. doi: 10.1345/aph.19171. Ann Pharmacother. 2000. PMID: 10928401 Review.
60 results